PTK2 and pancreatic neoplasm: This observation is consistent with previous reports identifying a reduction in fibroblast infiltration into pancreatic tumours following treatment with a FAK inhibitor [7], and builds on our previous finding that FAK-dependent expression of the chemokine CCL5 in cancer cells was required to drive elevated levels of Tregs into SCC tumours [5].